Financials data is unavailable for this security.
View more
Year on year Incyte Corp grew net income 75.42% from 340.66m to 597.60m primarily through revenue growth (3.39bn to 3.70bn). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 8.87% growth in revenues contributed enough to still see net income improve.
| Gross margin | 93.37% |
|---|---|
| Net profit margin | 0.80% |
| Operating margin | -1.30% |
| Return on assets | 0.57% |
|---|---|
| Return on equity | 0.80% |
| Return on investment | 0.74% |
More ▼
Cash flow in USDView more
In 2023, Incyte Corp increased its cash reserves by 8.88%, or 262.10m. The company earned 496.49m from its operations for a Cash Flow Margin of 13.43%. In addition the company used 207.68m on investing activities and also paid 20.03m in financing cash flows.
| Cash flow per share | 0.5567 |
|---|---|
| Price/Cash flow per share | 112.30 |
| Book value per share | 16.45 |
|---|---|
| Tangible book value per share | 15.02 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.87 |
|---|---|
| Quick ratio | 1.82 |
| Total debt/total equity | 0.0101 |
|---|---|
| Total debt/total capital | 0.01 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 73.89%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
| EPS growth(5 years) | 39.11 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -92.56 |
